Advanced search
Publication Cover
Psychiatry and Clinical Psychopharmacology Volume 29, 2019 - Issue 3
Journal homepage
7,209
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Levels of basophils and eosinophils are elevated while lymphocytes are reduced in patients with panic disorder compared to controls: a preliminary study

Mehmet Gurkan GurokSchool of Medicine, Department of Psychiatry, Fırat University, Elazig, TurkeyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-8998-0743
ORCID Icon,
Seda YılmazElazig Mental Health Hospital, Elazig, Turkey
,
Abdulgani TemizkanDepartment of Psychiatry, Adiyaman University Training and Research Hospital, Adiyaman, Turkey
,
Bilal UstundagSchool of Medicine, Department of Clinical Biochemistry, Fırat University, Elazig, Turkey
&
Murad AtmacaSchool of Medicine, Department of Psychiatry, Fırat University, Elazig, Turkey
Pages 315-319 | Received 21 Feb 2018, Accepted 12 May 2018, Published online: 30 May 2018

References

  • Yasui-Furukori Sato Y, Kato H, Kaneko S. Paroxetine-associated hypereosinophilia may clinically resemble a panic attack. Clin Neuropharmacol. 2012;35(1):47–48.
  • Philibert RA, Crowe R, Ryu GY, et al. Transcriptional profiling of lymphoblast lines from subjects with panic disorder. Am J Med Genet B Neuropsychiatr Genet. 2007;144B(5):674–682.
  • Park JE, Kim SW, Park Q, et al. Lymphocyte subsets and mood states in panic disorder patients. J Korean Med Sci. 2005;20(2):215–219.
  • Tükel R, Arslan BA, Ertekin BA, et al. Decreased IFN-γ and IL-12 levels in panic disorder. J Psychosom Res. 2012;73(1):63–67.
  • Cokmus FP, Özmen E, Alkın T, et al. Evaluation of serum MicroRNA expression profiles in patients with panic disorder. Psychiatry Clin Psychopharmacol. 2018. In Press.
  • Bez Y, Ari M, Ozturk OH, et al. Plasma nesfatin-1 level may be associated with disease severity in patients with panic disorder. Klinik Psikofarmakoloji Bülteni. 2010;20(4):288–292.
  • Han Almis B, Aksoy I. Mean platelet volume level in patients with generalized anxiety disorder. Psychiatry Clin Psychopharmacol. 2018;28(1):43–47.
  • Ayhan MG, Cicek IE, Inanli İ, et al. Neutrophil/lymphocyte and platelet/lymphocyte ratios in all mood states of bipolar disorder. Psychiatry Clin Psychopharmacol. 2017;27(3):284–288.
  • Uçar HN, Eray Ş, Murat D. Simple peripheral markers for inflammation in adolescents with major depressive disorder. Psychiatry Clin Psychopharmacol. 2018. In Press.
  • Klein DF. False suffocation alarms, spontaneous panic and related conditions: an integrative hypothesis. Arch Gen Psychiatry. 1993;50(4):306–317.
  • Ross DC, Preter M, Klein DF. Hematologic alterations and CO2 hypersensitivity in male panic disorder patients and normal controls: similarities to high-altitude hypoxia and chronic lung disease. Depress Anxiety. 2001;14(2):153–154.
  • Jasnoski M, Bell I, Peterson R. What connections exist between panic symptoms, shyness, type I hypersensitivity, anxiety, and anxiety sensitivity. Anxiety Stress Coping. 1994;7:19–34.
  • Rapaport MH. Circulating lymphocyte phenotypic surface markers in anxiety disorder patients and normal volunteers. Biol Psychiatry. 1998;43(6):458–463.
  • Atmaca M, Kilic F, Koseoglu F, et al. Neutrophils are decreased in obsessive-compulsive disorder: preliminary investigation. Psychiatry Investig. 2011;8(4):362–365.
  • Rasmussen SA, Eisen JL. The epidemiology and differential diagnosis of obsessive-compulsive disorder. J Clin Psychiatry. 1994;55(suppl.):5–10.
  • Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967;6(4):278–296.
  • Bandelow B. Assessing the efficacy of treatment for panic disorder and agoraphobia. II. The panic and agoraphobia scale. Int Clin Psychopharmacol. 1995;10(2):73–82.
  • Akdemir A, Örsel S, Dağ İ, et al. Hamilton Depresyon Derecelendirme Ölçeği (HDDÖ)’nin geçerliği, güvenirliği ve klinikte kullanımı. 3P Dergisi. 1996;4:251–259.
  • Tural Ü, Fidaner H, Alkın T, et al. Panik Agorafobi Ölçeği (PAÖ) Türkçe Uyarlaması. Türk Psikiyatri Dergisi. 2000;11:1.
  • Balon R, Rainey JM, Yeragani VK, et al. Hemoglobin and erythrocyte indices in panic disorder. Am J Psychiatry. 1987;144(4):539–540.
  • Carr DB, Sheehan DV, Surman OS, et al. Neuroendocrine correlates of lactate-induced anxiety and their response to chronic alprazolam therapy. Am J Psychiatry. 1986;143(4):483–494.
  • Kennedy BL, Morris RL, Schwab JJ. Allergy in panic disorder patients: a preliminary report. Gen Hosp Psychiatry. 2002;24(4):265–268.
  • Schmidt-Traub S, Bamler K. Psychoimmunologischer zusammenhang zwischen allergien, panik unc agoraphobie. Qeitschrift Klin. Psychol Psychopath Psychother. 1992;40:325–345.
  • Kim Y-R, Park Q, Yu B-H. Changes in lymphocyte subsets after short-term pharmacotherapy in patients with panic disorder. Psychiatry Res. 2004;128(2):183–190.
  • Schleifer SJ, Keller SE, Scott BJ, et al. Lymphocyte function in panic disorder. Biol Psychiatry. 1990;27(9):66.
  • Marazziti D, Ambrogi F, Vanacore R, et al. Immune cell imbalance in major depressive and panic disorders. Neuropsychobiology. 1992;26(1–2):23–26.
  • Fardet L, Petersen I, Nazareth I. Suicidal behavior and severe neuropsychiatric disorders following glucocorticoid therapy in primary care. Am J Psychiatry. 2012;169:491–497.
  • Yoshimura C, Miyamasu M, Nagase H, et al. Glucocorticoids induce basophil apoptosis. J Allergy Clin Immunol. 2001;108(2):215–220.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.